World's Best Scientists 2026 revealed!
Lishomwa C. Ndhlovu

Lishomwa C. Ndhlovu

D-Index & Metrics

Immunology

D-Index
44
Citations
8981
World Ranking
4763
National Ranking
2138

Lishomwa C. Ndhlovu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lishomwa C. Ndhlovu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 239 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lishomwa C. Ndhlovu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lishomwa C. Ndhlovu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lishomwa C. Ndhlovu is affiliated with Cornell University in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on specific subfields such as Immunology, Virology, Molecular Biology, Infectious Diseases, and Emergency Medicine.

Their work addresses several key topics, including:

  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • Immune Cell Function and Interaction
  • Epigenetics and DNA Methylation
  • Galectins and Cancer Biology
  • COVID-19 Clinical Research Studies

The scientist has contributed to numerous publications across various prominent venues. The most frequent publication platforms include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Immunology
  • AIDS
  • Frontiers in Immunology
  • AIDS Research and Human Retroviruses

Selected recent papers authored or co-authored by Lishomwa C. Ndhlovu include:

  • CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14, 2020, International Journal of Infectious Diseases
  • Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19, 2021, Journal of Leukocyte Biology
  • Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease, 2020, Gastroenterology
  • Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue, 2022, Nature Biotechnology
  • Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons, 2022, mBio

Frequent co-authors collaborating with Ndhlovu include:

  • Thomas A. Premeaux
  • Michael J. Corley
  • Alina P.S. Pang
  • Scott Bowler
  • Cecilia M. Shikuma

Best Publications

  • Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

    R. Brad Jones;Lishomwa C Ndhlovu;Jason D. Barbour;Prameet M. Sheth

  • Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity

    Lishomwa C. Ndhlovu;Sandra Lopez-Vergès;Jason D. Barbour;R. Brad Jones

  • Distinct Roles for the OX40-OX40 Ligand Interaction in Regulatory and Nonregulatory T Cells

    Ikuo Takeda;Shoji Ine;Nigel Killeen;Lishomwa C. Ndhlovu

  • Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand

    Kazuko Murata;Naoto Ishii;Hiroshi Takano;Shigeto Miura

  • TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

    Glen M. Chew;Tsuyoshi Fujita;Tsuyoshi Fujita;Gabriela M. Webb;Benjamin J. Burwitz;Benjamin J. Burwitz

  • Tregs control the development of symptomatic West Nile virus infection in humans and mice

    Marion C. Lanteri;Katie M. O’Brien;Whitney E. Purtha;Mark J. Cameron

  • Constitutive OX40/OX40 Ligand Interaction Induces Autoimmune-Like Diseases

    Kazuko Murata;Masato Nose;Lishomwa C. Ndhlovu;Takayuki Sato

  • T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection

    Keith E Garrison;R. Brad Jones;Duncan A Meiklejohn;Naveed Anwar

  • Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons

    Unknown

  • T Cell Ig and Mucin Domain-Containing Protein 3 Is Recruited to the Immune Synapse, Disrupts Stable Synapse Formation, and Associates With Receptor Phosphatases

    Kiera L. Clayton;Matthew S. Haaland;Matthew B. Douglas-Vail;Shariq Mujib

  • Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells.

    Shuming Chen;Naoto Ishii;Shouji Ine;Syuichi Ikeda

  • Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeficiency Virus Type 1 Infection

    Brian R. Long;Lishomwa C. Ndhlovu;Jorge R. Oksenberg;Lewis L. Lanier

  • CCR5 Inhibition in Critical COVID-19 Patients Decreases Inflammatory Cytokines, Increases CD8 T-Cells, and Decreases SARS-CoV2 RNA in Plasma by Day 14.

    Bruce K. Patterson;Harish Seethamraju;Kush Dhody;Michael J. Corley

  • Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis.

    Lishomwa C. Ndhlovu;Naoto Ishii;Kazuko Murata;Takayuki Sato

  • Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.

    Mayte Suárez-Fariñas;Minami Tokuyama;Gabrielle Wei;Ruiqi Huang

  • Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.

    Michael J. Corley;Alina P.S. Pang;Alina P.S. Pang;Kush Dody;Philip A. Mudd

  • Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4

    Jeffrey M. Milush;Brian R. Long;Jennifer E. Snyder-Cappione;Amedeo J. Cappione

  • Soluble T Cell Immunoglobulin Mucin Domain 3 Is Shed from CD8+ T Cells by the Sheddase ADAM10, Is Increased in Plasma during Untreated HIV Infection, and Correlates with HIV Disease Progression

    Kiera L. Clayton;Matthew B. Douglas-Vail;A. K. M. Nur-ur Rahman;Karyn E. Medcalf

  • Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19

    Bruce Pattterson;Harish Seetthamraju;Kush Dhody;Michael Corley

  • Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection

    Lishomwa C Ndhlovu;Joan M Chapman;Aashish R Jha;Jennifer E Snyder-Cappione

  • Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)

    Lishomwa C. Ndhlovu;Tracie Umaki;Glen M. Chew;Dominic C. Chow

Frequent Co-Authors

Douglas F. Nixon
Douglas F. Nixon Cornell University
Philip J. Norris
Philip J. Norris University of California, San Francisco
Mario A. Ostrowski
Mario A. Ostrowski University of Toronto
Sheila M. Keating
Sheila M. Keating University of California, San Francisco
Naoto Ishii
Naoto Ishii Tohoku University
Jonah B. Sacha
Jonah B. Sacha Oregon Health & Science University
Kazuo Sugamura
Kazuo Sugamura Tohoku University
Frederick Hecht
Frederick Hecht University of California, San Francisco
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Esper G. Kallas
Esper G. Kallas Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their knowledge while exploring careers related to immunology, several accessible nursing programs offer a practical pathway. Many students start with an easiest accelerated nursing programs that allow for faster completion and direct entry into clinical roles.

If you’re seeking a more foundational role in healthcare, consider exploring accredited LPN programs easy to get into. These programs offer solid clinical experience and serve as a springboard for further specialization.

For advanced practice opportunities, identifying what is the easiest NP program can help streamline the path to becoming a certified nurse practitioner. This is an ideal step for those aiming to specialize in immunology-related patient care.

Specialists in mental health nursing might also find value in the best online psychiatric mental health nurse practitioner programs. These programs emphasize clinical placements, ensuring hands-on experience in psychiatric care, which often intersects with immunological health issues.

Best Scientists Citing Lishomwa C. Ndhlovu

Trending Scientists